Innovators, The Bitch is Back
Meet Darren Cunningham, CEO of Inflection BioSciences, an early-stage drug development company focused on discovering and developing innovative small molecule therapeutics to treat cancer and cancer recurrences.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.